Categories: BodyDevelopmentPlatformRecruitingTechnology
We develop cutting-edge immuno-therapeutics with unparalleled efficacy and durability, specifically designed to combat tumors with low immunogenicity. About Us Attivare Therapeutics, founded by a dedicated team from the Wyss Institute at Harvard, is focused on tackling the formidable challenge of treating tumors with low immunogenicity. Our innovative approach centers around the development of the ATTImmune
Investors 3
Mentions in press and media 1
| Date | Title | Description |
| 15.12.2025 | Attivare Therapeutics Receives $6.6M Grant | Attivare Therapeutics, a Natick, MA-based company treating tumors with low immunogenicity, received $6.6M in grant from Gates Foundation.
The company intends to allocate the amount for the advancement of a new long-lasting malaria vaccine, ... |
Reviews 0
